Cargando…

The Enhanced Cytotoxic Effects in B-Cell Leukemia and Lymphoma Following Activation of Prostaglandin EP4 Receptor and Targeting of CD20 Antigen by Monoclonal Antibodies

Anti-CD20 monoclonal antibodies (MAbs) have revolutionized the treatment of B-cell leukemia and lymphoma. However, many patients do not respond to such treatment due to either deficiency of the complementary immune response or resistance to apoptosis. Other currently available treatments are often i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Markovič, Tijana, Podgornik, Helena, Avsec, Damjan, Nabergoj, Sanja, Mlinarič-Raščan, Irena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835876/ https://www.ncbi.nlm.nih.gov/pubmed/35163524 http://dx.doi.org/10.3390/ijms23031599

Ejemplares similares

Targeting Autophagy Triggers Apoptosis and Complements the Action of Venetoclax in Chronic Lymphocytic Leukemia Cells
por: Avsec, Damjan, et al.
Publicado: (2021)

Inhibition of p38 MAPK or immunoproteasome overcomes resistance of chronic lymphocytic leukemia cells to Bcl-2 antagonist venetoclax
por: Avsec, Damjan, et al.
Publicado: (2022)

Harnessing the untapped potential of nucleotide‐binding oligomerization domain ligands for cancer immunotherapy
por: Nabergoj, Sanja, et al.
Publicado: (2018)

A Putative Serine Protease is Required to Initiate the RIPK3-MLKL—Mediated Necroptotic Death Pathway in Neutrophils
por: Wang, Xiaoliang, et al.
Publicado: (2021)

Selective Cytotoxicity of Amidinopiperidine Based Compounds Towards Burkitt’s Lymphoma Cells Involves Proteasome Inhibition
por: Gobec, Martina, et al.
Publicado: (2012)

Discovery of Novel Small-Molecule Compounds with Selective Cytotoxicity for Burkitt’s Lymphoma Cells Using 3D Ligand-Based Virtual Screening
por: Gobec, Martina, et al.
Publicado: (2014)

A Double-Edged Kinase Lyn: A Positive and Negative Regulator for Antigen Receptor–mediated Signals
por: Nishizumi, Hirofumi, et al.
Publicado: (1998)

Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity
por: Guzelj, Samo, et al.
Publicado: (2021)

Pharmacogenetics of thiopurine therapy: from thiopurine S-methyltransferase to S-adenosylmethionine
por: Mlinarič-Raščan, Irena, et al.
Publicado: (2009)

PACSIN2 polymorphism is associated with thiopurine-induced hematological toxicity in children with acute lymphoblastic leukaemia undergoing maintenance therapy
por: Smid, Alenka, et al.
Publicado: (2016)

Association of ITPA Genotype with Event-Free Survival and Relapse Rates in Children with Acute Lymphoblastic Leukemia Undergoing Maintenance Therapy
por: Smid, Alenka, et al.
Publicado: (2014)

Effect of bacterial growth rate on bacteriophage population growth rate
por: Nabergoj, Dominik, et al.
Publicado: (2017)

A Myc-regulated transcriptional network controls B-cell fate in response to BCR triggering
por: Murn, Jernej, et al.
Publicado: (2009)

Cloning and expression of the rabbit prostaglandin EP2 receptor
por: Guan, Youfei, et al.
Publicado: (2002)

Polymorphism in Gene for ABCC2 Transporter Predicts Methotrexate Drug Survival in Patients with Psoriasis
por: Grželj, Jasna, et al.
Publicado: (2021)

Folate Insufficiency Due to MTHFR Deficiency Is Bypassed by 5-Methyltetrahydrofolate
por: Vidmar Golja, Maša, et al.
Publicado: (2020)

Regulation of prostaglandin EP(1) and EP(4) receptor signaling by carrier-mediated ligand reuptake
por: Chi, Yuling, et al.
Publicado: (2014)

Inhibitory effects of prostaglandin EP(4 )receptors on human eosinophils
por: Luschnig-Schratl, Petra, et al.
Publicado: (2009)

A Comprehensive Genetic Analysis of Slovenian Families with Multiple Cases of Orofacial Clefts Reveals Novel Variants in the Genes IRF6, GRHL3, and TBX22
por: Slavec, Lara, et al.
Publicado: (2023)

Novel CD20 monoclonal antibodies for lymphoma therapy
por: Cang, Shundong, et al.
Publicado: (2012)

Role of EP(2) and EP(4) receptors in airway microvascular leak induced by prostaglandin E(2)
por: Jones, Victoria C, et al.
Publicado: (2016)

The role of the EP receptors for prostaglandin E(2) in skin and skin cancer
por: Rundhaug, J. E., et al.
Publicado: (2011)

Prostaglandin E receptor 4 (EP4) promotes colonic tumorigenesis
por: Chang, Jian, et al.
Publicado: (2015)

Gene expression of prostaglandin EP4 receptor in three canine carcinomas
por: Musser, Margaret L., et al.
Publicado: (2020)

Prostaglandin E2/EP Signaling in the Tumor Microenvironment of Colorectal Cancer
por: Mizuno, Rei, et al.
Publicado: (2019)

Prostaglandin E2 receptor EP1 expression in vulvar cancer
por: Buchholz, Anna, et al.
Publicado: (2022)

Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma in Switzerland, 20 years of experience: 2001–2020
por: Simeunovic, Helena, et al.
Publicado: (2022)

Prostaglandin E2 promotes human CD34(+) cells homing through EP2 and EP4 in vitro
por: Wang, Yaqun, et al.
Publicado: (2017)

Concerted EP2 and EP4 Receptor Signaling Stimulates Autocrine Prostaglandin E(2) Activation in Human Podocytes
por: Mangelsen, Eva, et al.
Publicado: (2020)

The prostaglandin receptor EP2 determines prognosis in EP3-negative and galectin-3-high cervical cancer cases
por: Dietlmeier, Sebastian, et al.
Publicado: (2020)

A Common Polymorphism in the MTHFD1 Gene Is a Modulator of Risk of Congenital Heart Disease
por: Karas Kuželički, Nataša, et al.
Publicado: (2022)

The monoclonal antibody to cytotoxic T lymphocyte antigen 4, ipilimumab, in the treatment of melanoma
por: Verschraegen, Claire
Publicado: (2012)

Prostaglandin receptors EP and FP are regulated by estradiol and progesterone in the uterus of ovariectomized rats
por: Blesson, Chellakkan S, et al.
Publicado: (2012)

Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor
por: Carlson, Noel G, et al.
Publicado: (2009)

Role of the Prostaglandin E(2) EP1 Receptor in Traumatic Brain Injury
por: Glushakov, Alexander V., et al.
Publicado: (2014)

Heterodimerization of the prostaglandin E2 receptor EP2 and the calcitonin receptor CTR
por: Matsubara, Shin, et al.
Publicado: (2017)

Grapiprant: an EP4 prostaglandin receptor antagonist and novel therapy for pain and inflammation
por: Kirkby Shaw, Kristin, et al.
Publicado: (2015)

EP20 Hypercalcaemia in sarcoidosis
por: Chopra, Tanya, et al.
Publicado: (2020)

The pharmacological effect of BGC20-1531, a novel prostanoid EP(4) receptor antagonist, in the Prostaglandin E(2) human model of headache
por: Antonova, Maria, et al.
Publicado: (2011)

Opposing effects of prostaglandin E(2) receptors EP3 and EP4 on mouse and human β-cell survival and proliferation
por: Carboneau, Bethany A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ala6cbh774m59l7tcv6btso5ib